High intraindividual variability of global myocardial 18F-FDG uptake over time

Journal of Nuclear Medicine

Volumn 49, Issue 9, 2008, Pages 1570-

  Zöphel, Klaus ^a   Kotzerke, Joerg ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CREATININE; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; THYROTROPIN;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CELL HETEROGENEITY; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG UPTAKE; ESOPHAGUS CANCER; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART MUSCLE INJURY; HEART RATE VARIABILITY; HORMONE BLOOD LEVEL; HUMAN; LETTER; LUNG METASTASIS; LYMPH NODE METASTASIS; NEOPLASM; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCAR;

EID: 51349100760     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.052571     Document Type: Letter

References (7)

1. 18F-FDG PET/CT. J Nucl Med. 2007;48:1662-1669.
2. 18F- fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys. 2006;66:845-851.
3. Zöphel K, Hölzel C, Dawel M, Hölscher T, Evers C, Kotzerke J. PET/CT demonstrates increased myocardial FDG uptake following irradiation therapy. Eur J Nucl Med Mol Imaging. 2007;34:1322-1323.
4. 18F-FDG PET. Nucl Med Commun. 2005;26:787-791.
5. de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98-101.
6. Lloyd S, Brocks C, Chatham JC. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am J Physiol Heart Circ Physiol. 2003;285:H163-H172.
7. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev. 2007;12:331-343.